Best in Biotech 10 Oct 2024
12 biotech unicorns revolutionizing the future of healthcare
Take a closer look at 12 biotech unicorns, with a worth of more than $1 billion, that are trying to revolutionize the biopharma industry.
Don't miss out on the next big biotech breakthrough
Get all the latest updates straight into your inbox!
Newsletter Signup - Home CTA
"*" indicates required fields
-
Best in BiotechOctober 14, 2024Six biomimicry biotech companies harnessing nature’s wisdom to develop breakthrough drug candidates
-
PodcastOctober 11, 2024Bispecific ADCs: the next generation of cancer treatments
-
Expert AdviceOctober 11, 2024How to build your biotech company in 2024 (according to founders)?
-
News and TrendsOctober 10, 2024Second biotech IPO boom of the year: what does it mean for the industry?
- Latest Posts
- Popular Posts
In Depth 9 Oct 2024Promising cure for COPD: Is a breakthrough treatment within reach?
Find out whether a promising cure for COPD is within reach, after recent advancements in treatments and research around the disease.
In Depth 8 Oct 2024Top biotech deals of September 2024
There were a number of deals that stirred the biopharma industry in September. We have listed the major collaborations that took place last month.
How an innovative, data-driven approach is revolutionizing drug discovery for solid tumors
Learn how cancer tissue biobanks and insights into solid tumor heterogeneity are transforming drug discovery and paving the way for innovative treatments.
In Depth 7 Oct 2024Spinal cord injury: Are we getting closer to a treatment?
Delve into the spinal cord injury treatment landscape with a few pharmaceutical approaches that could tackle this complex condition.
In Depth 4 Oct 2024The biggest private biotech investments in September 2024
The companies Candid Therapeutics, ArsenalBio, and eGenesis bagged the biggest private biotech investments in September 2024.ADVERTISEMENT
ADVERTISEMENT
Podcast 4 Oct 2024Targeting telomerase to disrupt cancer
Listen to our conversation with Vlad Vitoc, CEO of MAIA, on the pioneering approach of telomere targeting
Best in Biotech 3 Oct 2024Six biotechs driving progress in Duchenne muscular dystrophy
In this article, we take a look at six clinical-stage biotechs that are fostering R&D in the Duchenne muscular dystrophy therapeutic space.
News and Trends 3 Oct 2024Resolution Therapeutics raises $85 million to advance its macrophage therapy
Find out about Resolution Therapeutics’ macrophage therapy, as it just raised $85 million in a series B round.
News and Trends 2 Oct 2024Niemann-Pick disease: FDA approves first two drugs in the space of a week for rare disorder
Find out all about the first two FDA drug approvals for the rare genetic disorder Niemann-Pick disease type C.
Best in Biotech 1 Oct 2024Lithuania’s biotech: Six companies to put on your radar
Here are six companies at the forefront of Lithuania’s growing biotech scene, showcasing innovations in protein engineering and gene editing.
Sublingual delivery of GLP-1 receptor agonists
Discover how GLP-1 receptor agonists, now thriving in obesity treatment, could benefit from a more patient-friendly sublingual delivery method.
Expert Advice 2 Feb 20245 biotech career paths where demand is skyrocketing
Check out five important biotechnology careers that are currently in high demand, and likely still will be in the coming years.
Best in Biotech 12 Mar 2024The twelve hottest biotech companies in the Boston area
Explore Boston’s vibrant biotech landscape with twelve innovative companies leading the charge in life sciences research.
In Depth 12 Feb 2024RNA editing set to take off: could DNA’s short-lived cousin overcome the limitations of CRISPR gene editing?
Find out all about about RNA editing, as two candidates have just managed to reach the clinic for the first time.
In Depth 15 Jan 2024The future of diabetes treatment: Is a cure possible?
Diabetes has become an epidemic. Science is striving to find a diabetes treatment that can cure this chronic disease, but how close are we?
In Depth 8 Feb 2024Could we see a new dawn for hair loss treatments?
Discover the latest advances in hair loss treatments, from topical therapies to the the groundbreaking potential of JAK inhibitors.
Best in Biotech 5 Jan 2024Five AI drug discovery companies you should know about
Take a look at five of the top AI drug discovery companies around today, using their technology to speed up the drug discovery process.
Expert Advice 15 Mar 2024Is biotechnology a good career? Here are the pros and cons
Find out about the pros and cons of pursuing a career in biotechnology, from competitive salaries to dealing with regulatory hurdles.
In Depth 9 Feb 2024Biotech job market 2024: what to expect?
The past year saw pipeline cuts and downsizing plans strike the biotech industry. Does the biotech job market seem to be looking up this year?
Podcast 19 Jan 2024Epigenetic editing – the power of CRISPR without cutting DNA
Epic Bio is an epigenetic editing company, leveraging the power of CRISPR without cutting DNA. The company’s proprietary Gene Expression Modulation System (GEMS) includes the smallest Cas protein known to work in human cells. This enables in vivo or ex vivo delivery via a single viral vector. Epic’s lead program, EPI-321, is in IND-enabling studies […]
Best in Biotech 12 Apr 20246 biotechnology universities in the US nurturing tomorrow’s trailblazers
Discover the top biotechnology universities in the US offering cutting-edge programs that are helping students find a career in biotech.
In Depth 8 Jul 2024Bridge RNA: A new gene editing technique that could overcome the limitations of CRISPR
Find out how the recent discovery of a molecular oddity found in bacteria has led to a new gene editing technique.
Best in Biotech 13 Feb 2024Eight biotechs thriving in Seattle
In this article, let us take a look at some of the major biotech companies in Seattle that are contributing to the biotech industry at large.
ADVERTISEMENT